SCHEMBL20182241

SCHEMBL20182241

CC(/C(=C/Nc1ccccc1F)N=N)n1cc(-c2ccc(C#N)c(F)c2)c2c(N)ncnc21

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KDR P35968 10/20 0.46
SRC P12931 6/20 0.46
PIK3CD O00329 4/20 0.46
PIK3CA P42336 4/20 0.46
PIK3CB P42338 4/20 0.46
PIK3CG P48736 4/20 0.46
PRKDC P78527 4/20 0.46
ABL1 P00519 4/20 0.46
EGFR P00533 4/20 0.46
HCK P08631 3/20 0.46
MTOR P42345 3/20 0.46
EPHB4 P54760 3/20 0.46
TEK Q02763 7/20 0.45
LCK P06239 4/20 0.41
FLT3 P36888 2/20 0.38
NEK7 Q8TDX7 3/20 0.37
EIF2AK3 Q9NZJ5 1/20 0.37
ABL2 P42684 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20182362 0.83 CFTR (0.40) KDRSRCPIK3CDPIK3CAPIK3CB
SCHEMBL20182228 0.82 KDR (0.45) KDRSRCEGFRHCKMTOR
SCHEMBL20182200 0.81 KDR (0.39) KDRSRCPIK3CDPIK3CAPIK3CB
SCHEMBL20182274 0.79 EIF2AK3 (0.40) KDRSRCPIK3CDPIK3CAPIK3CB
SCHEMBL20181904 0.78 PDPK1 (0.36) KDRSRCPIK3CDPIK3CAPIK3CB
SCHEMBL20181883 0.78 NTRK1 (0.40) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL20182283 0.77 NTRK1 (0.36) KDRSRCPIK3CDPIK3CAPIK3CB
SCHEMBL20181907 0.77 EGFR (0.35) KDRSRCABL1EGFRMTOR
SCHEMBL20181912 0.77 SRC (0.41) KDRSRCPIK3CDPIK3CAPIK3CB
SCHEMBL20182295 0.76 MTOR (0.33) KDRSRCPIK3CDPIK3CAPIK3CB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018094137-A1 PYRROLOPYRIMIDINES AS CFTR POTENTIATORS CYSTIC FIBROSIS FOUNDATION THERAPEUTICS INC. (US) 2018-05-24 WO disclosed